Lexapro and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Lexapro (escitalopram oxalate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Klonopin, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Lexapro. It is created by eHealthMe based on reports of 82,231 people who have side effects when taking Lexapro from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,455 Lexapro users. Check the latest studies of Lexapro.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,142 drugs and 1,403 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Dec, 03, 2025

82,231 people reported to have side effects when taking Lexapro.
Among them, 58 people (0.07%) have Hyperthyroid.

Among these 58 people:

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lexapro:

Lexapro (91,455 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,828 reports)

How severe was Hyperthyroid and when was it recovered:

Hyperthyroid in Lexapro

Expand to all the drugs that have ingredients of escitalopram oxalate:

Hyperthyroid and drugs with ingredients of escitalopram oxalate (115 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Lexapro side effects:

Lexapro side effect: Depression (5,337 reports)
Lexapro side effect: Drug ineffective (4,848 reports)

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Hyperthyroid:

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,142 drugs)

Common conditions associated with Hyperthyroid:

Atrial fibrillation: 1,072 reports
Low thyroid: 958 reports
Hypothyroidism: 957 reports
Hypertension aggravated: 904 reports
High blood pressure: 900 reports
Multiple sclerosis aggravated: 693 reports
Malignant melanoma: 553 reports
Pain: 444 reports
Osteoporosis: 434 reports
Hypnosis and pain: 433 reports

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,403 conditions)

Drugs similar to Lexapro and Hyperthyroid :

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Lexapro) and Lexapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.